Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway

References

• Hernandez C, Shukla S. Liposome based drug delivery as a potential treatment option for Alzheimer’s disease. Neural Regen Res. 2022;17(6):1190–1198. doi:10.4103/1673-5374.327328
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;394(10204):1145–1158. doi:10.1016/S0140-6736(19)30427-1
   PubMed Web of Science ®Google Scholar
• Jia J, Wei C, Chen S, et al. The cost of Alzheimer’s disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483–491. doi:10.1016/j.jalz.2017.12.006
   PubMed Web of Science ®Google Scholar
• Ren R, Qi J, Lin S, et al. The China Alzheimer report 2022. Gen Psychiatr. 2022;35(1):e100751. doi:10.1136/gpsych-2022-100751
   PubMed Web of Science ®Google Scholar
• Lee PJ, Tsai CL, Liang CS, et al. Biomarkers with plasma amyloid β and tau protein assayed by immunomagnetic reduction in patients with amnestic mild cognitive impairment and Alzheimer’s disease. Acta Neurol Taiwan. 2022;31(2):53–60.
   Google Scholar
• Srivastava P, Tripathi PN, Sharma P, et al. Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory. Eur J Med Chem. 2019;163:116–135. doi:10.1016/j.ejmech.2018.11.049
   PubMed Web of Science ®Google Scholar
• Tripathi PN, Srivastava P, Sharma P, et al. Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg Chem. 2019;85:82–96. doi:10.1016/j.bioorg.2018.12.017
   PubMed Web of Science ®Google Scholar
• Rai SN, Tiwari N, Singh P, et al. Therapeutic potential of vital transcription factors in alzheimer’s and parkinson’s disease with particular emphasis on transcription factor EB mediated autophagy. Front Neurosci. 2021;15:777347. doi:10.3389/fnins.2021.777347
   PubMed Web of Science ®Google Scholar
• Hou J, Jeon B, Baek J, et al. High fat diet-induced brain damaging effects through autophagy-mediated senescence, inflammation and apoptosis mitigated by ginsenoside F1-enhanced mixture. J Ginseng Res. 2022;46(1):79–90. doi:10.1016/j.jgr.2021.04.002
   PubMed Web of Science ®Google Scholar
• Abdel Moneim AE. The neuroprotective effect of berberine in mercury-induced neurotoxicity in rats. Metab Brain Dis. 2015;30(4):935–942. doi:10.1007/s11011-015-9652-6
   PubMed Web of Science ®Google Scholar
• Singh AK, Rai SN, Maurya A, et al. Therapeutic potential of phytoconstituents in management of Alzheimer’s disease. Evid Based Complement Alternat Med. 2021;2021:5578574. doi:10.1155/2021/5578574
   PubMed Web of Science ®Google Scholar
• Peng C, Han J, Ye X, et al. IL-33 treatment attenuates the systemic inflammation reaction in acinetobacter baumannii pneumonia by suppressing TLR4/NF-κB signaling. Inflammation. 2018;41(3):870–877. doi:10.1007/s10753-018-0741-7
   PubMed Web of Science ®Google Scholar
• Li Y, Wang B, Liu C, et al. Inhibiting c-Jun N-terminal kinase (JNK)-mediated apoptotic signaling pathway in PC12 cells by a polysaccharide (CCP) from Coptis chinensis against Amyloid-β (Aβ)-induced neurotoxicity. Int J Biol Macromol. 2019;134:565–574. doi:10.1016/j.ijbiomac.2019.05.041
   PubMed Web of Science ®Google Scholar
• Lou Y, Wang C, Tang Q, et al. Paeonol inhibits IL-1β-induced inflammation via PI3K/Akt/NF-κB pathways: in vivo and vitro studies. Inflammation. 2017;40(5):1698–1706. doi:10.1007/s10753-017-0611-8
   PubMed Web of Science ®Google Scholar
• Tian H, Ding N, Guo M, et al. Analysis of learning and memory ability in an Alzheimer’s disease mouse model using the Morris water maze. J Vis Exp. 2019;152. doi:10.3791/60055
   Google Scholar
• Cardiff RD, Miller CH, Munn RJ. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc. 2014;2014(6):655–658. doi:10.1101/pdb.prot073411
   PubMedGoogle Scholar
• Lundberg DS, Yourstone S, Mieczkowski P, et al. Practical innovations for high-throughput amplicon sequencing. Nat Methods. 2013;10(10):999–1002. doi:10.1038/nmeth.2634
   PubMed Web of Science ®Google Scholar
• Ni D, Xu P, Gallagher S. Immunoblotting and immunodetection. Curr Protoc Cell Biol. 2017;74. doi:10.1002/cpcb.18
   PubMedGoogle Scholar
• Knopp RC, Baumann KK, Wilson ML, et al. Amyloid beta pathology exacerbates weight loss and brain cytokine responses following low-dose lipopolysaccharide in aged female Tg2576 mice. Int J Mol Sci. 2022;23(4):2377. doi:10.3390/ijms23042377
   PubMed Web of Science ®Google Scholar
• Patrick RP. Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer’s disease. FASEB J. 2019;33(2):1554–1564. doi:10.1096/fj.201801412R
   PubMed Web of Science ®Google Scholar
• Yang W, Liu Y, Xu QQ, et al. Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K/Akt/GSK-3 β pathway in experimental models of alzheimer’s disease. Oxid Med Cell Longev. 2020;2020:4754195. doi:10.1155/2020/4754195
   PubMed Web of Science ®Google Scholar
• Zhou J, Yu W, Zhang M, et al. Imbalance of microglial TLR4/TREM2 in LPS-Treated APP/ps1 transgenic mice: a potential link between alzheimer’s disease and systemic inflammation. Neurochem Res. 2019;44(5):1138–1151. doi:10.1007/s11064-019-02748-x
   PubMed Web of Science ®Google Scholar
• Thu Thuy Nguyen V, Endres K. Targeting gut microbiota to alleviate neuroinflammation in Alzheimer’s disease. Adv Drug Deliv Rev. 2022;188:114418. doi:10.1016/j.addr.2022.114418
   PubMed Web of Science ®Google Scholar
• Jin X, Liu MY, Zhang DF, et al. Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF-κB signaling pathway. CNS Neurosci Ther. 2019;25(5):575–590. doi:10.1111/cns.13086
   PubMed Web of Science ®Google Scholar
• Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer’s Disease. Curr Neuropharmacol. 2020;18(11):1106–1125. doi:10.2174/1570159X18666200528142429
   PubMed Web of Science ®Google Scholar
• Nedelec T, Couvy-Duchesne B, Monnet F, et al. Identifying health conditions associated with Alzheimer’s disease up to 15 years before diagnosis: an agnostic study of French and British health records. Lancet Digit Health. 2022;4(3):e169–e178. doi:10.1016/S2589-7500(21)00275-2
   PubMedGoogle Scholar
• Fu P, Gao M, Yung KKL. Association of intestinal disorders with parkinson’s disease and alzheimer’s disease: a systematic review and meta-analysis. ACS Chem Neurosci. 2020;11(3):395–405. doi:10.1021/acschemneuro.9b00607
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang P, Li C, et al. A polysaccharide from Rosa roxburghii Tratt fruit attenuates high-fat diet-induced intestinal barrier dysfunction and inflammation in mice by modulating the gut microbiota. Food Funct. 2022;13(2):530–547. doi:10.1039/d1fo03190b
   PubMed Web of Science ®Google Scholar
• Sacks D, Baxter B, Campbell BCV, et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke. 2018;13(6):612–632. doi:10.1177/1747493018778713
   PubMed Web of Science ®Google Scholar
• Rai SN, Chaturvedi VK, Singh BK, et al. Commentary: trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the Aβ42: aβ40Ratio, and exacerbates axonal dystrophy and dendritic Spine Loss in the PS2APP Alzheimer’s mouse model. Front Aging Neurosci. 2020;12:219. doi:10.3389/fnagi.2020.00219
   PubMed Web of Science ®Google Scholar
• Chung J, Das A, Sun X, et al. Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer’s disease among women. Alzheimers Dement. 2022. doi:10.1002/alz.12719
   Google Scholar
• Gao S, Nguyen JT, Hendrie HC, et al. Accelerated weight loss and incident dementia in an elderly African-American cohort. J Am Geriatr Soc. 2011;59(1):18–25. doi:10.1111/j.1532-5415.2010.03169.x
   PubMed Web of Science ®Google Scholar
• Vamanu E, Rai SN. The link between obesity, microbiota dysbiosis, and neurodegenerative pathogenesis. Diseases. 2021;9(3):45. doi:10.3390/diseases9030045
   PubMedGoogle Scholar
• Sergi G, De Rui M, Coin A, et al. Weight loss and Alzheimer’s disease: temporal and aetiologic connections. Proc Nutr Soc. 2013;72(1):160–165. doi:10.1017/S0029665112002753
   PubMed Web of Science ®Google Scholar
• Hersoug LG, Møller P, Loft S. Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity. Nutr Res Rev. 2018;31(2):153–163. doi:10.1017/S0954422417000269
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu X, Li Y, et al. Jiedu-Yizhi formula improves cognitive impairment in an Aβ25-35-induced rat model of alzheimer’s disease by inhibiting pyroptosis. Evid Based Complement Alternat Med. 2022;2022:6091671. doi:10.1155/2022/6091671
   PubMed Web of Science ®Google Scholar
• Mattson MP. Emerging neuroprotective strategies for Alzheimer’s disease: dietary restriction, telomerase activation, and stem cell therapy. Exp Gerontol. 2000;35(4):489–502. doi:10.1016/s0531-5565(00)00115-7
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Mayeux R. Dietary factors and Alzheimer’s disease. Lancet Neurol. 2004;3(10):579–587. doi:10.1016/S1474-4422(04)00878-6
   PubMed Web of Science ®Google Scholar
• Rogers NT, Steptoe A, Cadar D. Frailty is an independent predictor of incident dementia: evidence from the English longitudinal study of ageing. Sci Rep. 2017;7(1):15746. doi:10.1038/s41598-017-16104-y
   PubMedGoogle Scholar
• Hu X, Okamura N, Arai H, et al. Neuroanatomical correlates of low body weight in Alzheimer’s disease: a PET study. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(7–8):1285–1289. doi:10.1016/s0278-5846(02)00291-9
   PubMed Web of Science ®Google Scholar
• Val-Laillet D, Aarts E, Weber B, et al. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. Neuroimage Clin. 2015;8:1–31. doi:10.1016/j.nicl.2015.03.016
   PubMed Web of Science ®Google Scholar
• Zhang Q, Jin K, Chen B, et al. Overnutrition induced cognitive impairment: insulin resistance, gut-brain axis, and neuroinflammation. Front Neurosci. 2022;16:884579. doi:10.3389/fnins.2022.884579
   PubMed Web of Science ®Google Scholar
• Mun YS, Park HK, Kim J, et al. Association between body mass index and cognitive function in mild cognitive impairment regardless of APOE ε4 status. Dement Neurocogn Disord. 2022;21(1):30–41. doi:10.12779/dnd.2022.21.1.30
   PubMedGoogle Scholar
• Tamura BK, Masaki KH, Blanchette P. Weight loss in patients with Alzheimer’s disease. J Nutr Elder. 2007;26(3–4):21–38. doi:10.1300/j052v26n03_02
   PubMedGoogle Scholar
• Rai SN, Singh C, Singh A, et al. Mitochondrial dysfunction: a potential therapeutic target to treat alzheimer’s disease. Mol Neurobiol. 2020;57(7):3075–3088. doi:10.1007/s12035-020-01945-y
   PubMed Web of Science ®Google Scholar
• La Joie R, Visani AV, Baker SL, et al. Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12(524):eaau5732. doi:10.1126/scitranslmed.aau5732
   PubMed Web of Science ®Google Scholar
• Blum D, Buée L. Alzheimer’s disease risk, obesity and tau: is insulin resistance guilty? Expert Rev Neurother. 2013;13(5):461–463. doi:10.1586/ern.13.35
   PubMed Web of Science ®Google Scholar
• Stefanoska K, Gajwani M, Tan ARP, et al. Alzheimer’s disease: ablating single master site abolishes tau hyperphosphorylation. Sci Adv. 2022;8(27):eabl8809. doi:10.1126/sciadv.abl8809
   PubMed Web of Science ®Google Scholar
• Chang CW, Shao E, Mucke L. Tau: enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies. Science. 2021;371(6532):eabb8255. doi:10.1126/science.abb8255
   PubMed Web of Science ®Google Scholar
• Bloom GS. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71(4):505–508. doi:10.1001/jamaneurol.2013.5847
   PubMed Web of Science ®Google Scholar
• Bonfili L, Cecarini V, Berardi S, et al. Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep. 2017;7(1):2426. doi:10.1038/s41598-017-02587-2
   PubMed Web of Science ®Google Scholar
• Bai X, Fu R, Duan Z, et al. Ginsenoside Rh4 alleviates antibiotic-induced intestinal inflammation by regulating the TLR4-MyD88-MAPK pathway and gut microbiota composition. Food Funct. 2021;12(7):2874–2885. doi:10.1039/d1fo00242b
   PubMed Web of Science ®Google Scholar
• Tang J, Xu L, Zeng Y, et al. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway. Int Immunopharmacol. 2021;91:107272. doi:10.1016/j.intimp.2020.107272
   PubMed Web of Science ®Google Scholar
• D’Amato A, Di Cesare Mannelli L, Lucarini E, et al. Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients. Microbiome. 2020;8(1):140. doi:10.1186/s40168-020-00914-w
   PubMed Web of Science ®Google Scholar
• Tran TTT, Corsini S, Kellingray L, et al. APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer’s disease pathophysiology. FASEB J. 2019;33(7):8221–8231. doi:10.1096/fj.201900071R
   PubMed Web of Science ®Google Scholar
• Binda C, Lopetuso LR, Rizzatti G, et al. Actinobacteria: a relevant minority for the maintenance of gut homeostasis. Dig Liver Dis. 2018;50(5):421–428. doi:10.1016/j.dld.2018.02.012
   PubMedGoogle Scholar
• Gureev AP, Syromyatnikov MY, Ignatyeva DA, et al. Effect of long-term methylene blue treatment on the composition of mouse gut microbiome and its relationship with the cognitive abilities of mice. PLoS One. 2020;15(11):e0241784. doi:10.1371/journal.pone.0241784
   PubMed Web of Science ®Google Scholar
• Wang S, Yao J, Zhou B, et al. Bacteriostatic effect of quercetin as an antibiotic alternative in vivo and its antibacterial mechanism in vitro. J Food Prot. 2018;81(1):68–78. doi:10.4315/0362-028X.JFP-17-214
   PubMed Web of Science ®Google Scholar
• Li L, Li R, Zhu R, et al. Salvianolic acid B prevents body weight gain and regulates gut microbiota and LPS/TLR4 signaling pathway in high-fat diet-induced obese mice. Food Funct. 2020;11(10):8743–8756. doi:10.1039/d0fo01116a
   PubMed Web of Science ®Google Scholar
• Mao B, Guo W, Tang X, et al. Inosine pretreatment attenuates LPS-induced lung injury through regulating the TLR4/MyD88/NF-κB signaling pathway in vivo. Nutrients. 2022;14(14):2830. doi:10.3390/nu14142830
   PubMed Web of Science ®Google Scholar
• Verhaar BJH, Hendriksen HMA, de Leeuw FA, et al. Gut microbiota composition is related to AD Pathology. Front Immunol. 2022;12:794519. doi:10.3389/fimmu.2021.794519
   PubMed Web of Science ®Google Scholar
• Wang X, Yu N, Wang Z, et al. Akebia trifoliata pericarp extract ameliorates inflammation through NF-κB/MAPK signaling pathways and modifies gut microbiota. Food Funct. 2020;11(5):4682–4696. doi:10.1039/c9fo02917f
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang M, Zhao X, et al. Ammonia exposure induced intestinal inflammation injury mediated by intestinal microbiota in broiler chickens via TLR4/TNF-α signaling pathway. Ecotoxicol Environ Saf. 2021;226:112832. doi:10.1016/j.ecoenv.2021.112832
   PubMed Web of Science ®Google Scholar
• Cui HX, Hu YN, Li JW, et al. Hypoglycemic mechanism of the berberine organic acid salt under the synergistic effect of intestinal flora and oxidative stress. Oxid Med Cell Longev. 2018;2018:8930374. doi:10.1155/2018/8930374
   PubMed Web of Science ®Google Scholar
• Liu J, Ye T, Zhang Y, et al. Protective effect of ginkgolide B against cognitive impairment in mice via regulation of gut microbiota. J Agric Food Chem. 2021;69(41):12230–12240. doi:10.1021/acs.jafc.1c05038
   PubMed Web of Science ®Google Scholar
• Zhang DD, Li HJ, Zhang HR, et al. Poria cocos water-soluble polysaccharide modulates anxiety-like behavior induced by sleep deprivation by regulating the gut dysbiosis, metabolic disorders and TNF-α/NF-κB signaling pathway. Food Funct. 2022;13(12):6648–6664. doi:10.1039/d2fo00811d
   PubMed Web of Science ®Google Scholar
• Davies DA, Adlimoghaddam A, Albensi BC. Role of Nrf2 in plasticity s and memory in alzheimer’s disease. Cells. 2021;10(8):1884. doi:10.3390/cells10081884
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lenardo MJ, Baltimore D. 30 Years of NF-κB: a blossoming of relevance to human pathobiology. Cell. 2017;168(1–2):37–57. doi:10.1016/j.cell.2016.12.012
   PubMed Web of Science ®Google Scholar
• Wan H, Han J, Tang S, et al. Comparisons of protective effects between two sea cucumber hydrolysates against diet induced hyperuricemia and renal inflammation in mice. Food Funct. 2020;11(1):1074–1086. doi:10.1039/c9fo02425e
   PubMed Web of Science ®Google Scholar
• Velloso LA, Folli F, Saad MJ. TLR4 at the crossroads of nutrients, gut microbiota, and metabolic inflammation. Endocr Rev. 2015;36(3):245–271. doi:10.1210/er.2014-1100
   PubMed Web of Science ®Google Scholar
• Akbar M, Shabbir A, Rehman K, et al. Neuroprotective potential of berberine in modulating Alzheimer’s disease via multiple signaling pathways. J Food Biochem. 2021;45(10):e13936. doi:10.1111/jfbc.13936
   PubMed Web of Science ®Google Scholar
• He W, Wang C, Chen Y, et al. Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation. Pharmacol Rep. 2017;69(6):1341–1348. doi:10.1016/j.pharep.2017.06.006
   PubMed Web of Science ®Google Scholar
• Živančević K, Baralić K, Bozic D, et al. Involvement of environmentally relevant toxic metal mixture in Alzheimer’s disease pathway alteration and protective role of berberine: bioinformatics analysis and toxicogenomic screening. Food Chem Toxicol. 2022;161:112839. doi:10.1016/j.fct.2022.112839
   PubMed Web of Science ®Google Scholar
• Lin X, Zhang N. Berberine: pathways to protect neurons. Phytother Res. 2018;32(8):1501–1510. doi:10.1002/ptr.6107
   PubMed Web of Science ®Google Scholar
• Yan T, Zhang X, Mao Q, et al. Alpinae Oxyphyllae Fructus alleviated LPS-induced cognitive impairments via PI3K/AKT/NF-κB signaling pathway. Environ Toxicol. 2022;37(3):489–503. doi:10.1002/tox.23415
   PubMed Web of Science ®Google Scholar
• Yin Z, Gao D, Du K, et al. Rhein Ameliorates Cognitive Impairment in an APP/PS1 transgenic mouse model of Alzheimer’s disease by relieving oxidative stress through activating the SIRT1/PGC-1α pathway. Oxid Med Cell Longev. 2022;2022:2524832. doi:10.1155/2022/2524832
   PubMed Web of Science ®Google Scholar
• Mank A, Rijnhart JJM, van Maurik IS, et al. A longitudinal study on quality of life along the spectrum of Alzheimer’s disease. Alzheimers Res Ther. 2022;14(1):132. doi:10.1186/s13195-022-01075-8
   PubMed Web of Science ®Google Scholar